(Q34973539)

English

CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973].

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973]. (English)

1 reference

Europe PubMed Central

5 August 2017

0 references

0 references

0 references

Chagas cardiomyopathy

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Franklin R Quiros

1

1 reference

Europe PubMed Central

5 August 2017

Carlos A Morillo

2

1 reference

Europe PubMed Central

5 August 2017

Juan P Casas

3

1 reference

Europe PubMed Central

5 August 2017

Luz A Cubillos

4

1 reference

Europe PubMed Central

5 August 2017

Federico A Silva

5

1 reference

Europe PubMed Central

5 August 2017

publication date

9 June 2006

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

7

1 reference

Europe PubMed Central

5 August 2017

21

1 reference

Europe PubMed Central

5 August 2017

https://scigraph.springernature.com/pub.10.1186/1745-6215-7-21

0 references

Guidelines for the diagnosis and treatment of chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538628

8 July 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538628

8 July 2018

A cost-minimization of heart failure therapy with bisoprolol in the French setting: an analysis from CIBIS trial data. Cardiac Insufficiency Bisoprolol Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538628

8 July 2018

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538628

8 July 2018

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538628

8 July 2018

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538628

8 July 2018

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538628

8 July 2018

Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538628

8 July 2018

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538628

8 July 2018

Chagas' heart disease in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538628

8 July 2018

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538628

8 July 2018

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-7-21

21 January 2018

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-7-21

21 January 2018

Chagas' heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538628

9 December 2018

Alteration of the pattern of β-adrenergic desensitization in cultured L6E9 muscle cells infected with Trypanosoma cruzi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538628

9 December 2018

Chronic Chagas' heart disease in children and adolescents: a clinicopathologic study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538628

9 December 2018

Chagas cardiomyopathy and captopril

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538628

9 December 2018

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16764726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus recommendations for the management of chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/16764726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16764726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/16764726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/16764726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1745-6215-7-21

1 reference

Europe PubMed Central

5 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34973539&oldid=1584878823"